Norway has submitted a proposal to restrict the manufacture, use and placing on the market of 1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) [covering any of its individual anti- and synisomers or any combination thereof] as substances, constituents of other substances, mixtures and articles.

This consultation is open from 23 June 2021 to 3 January 2022. ECHA’s scientific committees welcome early comments by 28 July 2021 to assist them in the first discussion of the proposal in September 2021.